TY - JOUR
T1 - Recruitment and treatment practices for help-seeking "prodromal" patients
AU - McGlashan, Thomas H.
AU - Addington, Jean
AU - Cannon, Tyrone
AU - Heinimaa, Markus
AU - McGorry, Patrick
AU - O'Brien, Mary
AU - Penn, David
AU - Perkins, Diana
AU - Salokangas, Raimo K R
AU - Walsh, Barbara
AU - Woods, Scott W.
AU - Yung, Alison
N1 - Peer Reviewed Journal References . McGlashan, Thomas H.: Department of Psychiatry, Yale University School of Medicine, New Haven, CT, US Addington, Jean: Department of Psychiatry, University of Toronto, Toronto, ON, Canada Cannon, Tyrone: Department of Psychiatry, University of California Los Angeles, Los Angeles, CA, US Heinimaa, Markus: Department of Psychiatry, University of Turku, Turku, Finland McGorry, Patrick: ORYGEN Research Centre, Department of Psychiatry, University of Melbourne, Melbourne, VIC, Australia O'Brien, Mary: Department of Psychiatry, University of California Los Angeles, Los Angeles, CA, US Penn, David: Department of Psychiatry, University of North Carolina, Chapel Hill, NC, US Perkins, Diana: Department of Psychiatry, University of North Carolina, Chapel Hill, NC, US Salokangas, Raimo K. R.: Department of Psychiatry, University of Turku, Turku, Finland Walsh, Barbara: Department of Psychiatry, Yale University School of Medicine, New Haven, CT, US Woods, Scott W.: Department of Psychiatry, Yale University School of Medicine, New Haven, CT, US Yung, Alison: ORYGEN Research Centre, Department of Psychiatry, University of Melbourne, Melbourne, VIC, Australia
PY - 2007/9
Y1 - 2007/9
N2 - The prodrome of psychosis has become a target for early identification and for treatments that address both symptoms and risk for future psychosis. Interest and activity in this realm is now worldwide. Clinical trials with rigorous methodology have only just begun, making treatment guidelines premature. Despite the sparse evidence base, treatments are currently applied to patients in the new prodromal clinics, usually treatments developed for established psychosis and modified for the prodromal phase. This communication will describe representative samplings of how treatment-seeking prodromal patients are currently recruited and treated in prodromal clinics worldwide. Recruitment includes how prodromal patients are sought, initially evaluated, apprised of their high-risk status, and informed of the risks and benefits of prodromal treatments and how their mental state is monitored over time. The treatment modalities offered (and described) include engagement, supportive therapy, case management, stress management, cognitive behavioral treatment, family-based treatment, antipsychotic pharmacotherapy, and non-antipsychotic pharmacotherapy. References for details are noted. © The Author 2007. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved.
AB - The prodrome of psychosis has become a target for early identification and for treatments that address both symptoms and risk for future psychosis. Interest and activity in this realm is now worldwide. Clinical trials with rigorous methodology have only just begun, making treatment guidelines premature. Despite the sparse evidence base, treatments are currently applied to patients in the new prodromal clinics, usually treatments developed for established psychosis and modified for the prodromal phase. This communication will describe representative samplings of how treatment-seeking prodromal patients are currently recruited and treated in prodromal clinics worldwide. Recruitment includes how prodromal patients are sought, initially evaluated, apprised of their high-risk status, and informed of the risks and benefits of prodromal treatments and how their mental state is monitored over time. The treatment modalities offered (and described) include engagement, supportive therapy, case management, stress management, cognitive behavioral treatment, family-based treatment, antipsychotic pharmacotherapy, and non-antipsychotic pharmacotherapy. References for details are noted. © The Author 2007. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved.
KW - At-risk
KW - Managing
KW - Schizophrenia
U2 - 10.1093/schbul/sbm025
DO - 10.1093/schbul/sbm025
M3 - Article
SN - 0586-7614
VL - 33
SP - 715
EP - 726
JO - Schizophrenia Bulletin
JF - Schizophrenia Bulletin
IS - 3
ER -